Repository logo

Title

Use of sodium-glucose cotransporter-2 inhibitors among Aboriginal people with type 2 diabetes in remote Northern Territory: 2012 to 2020.

Link to article in PubMed
https://pubmed.ncbi.nlm.nih.gov/39989248/?otool=iaurydwlib
Author(s)
Hare, Matthew  
Chen, Winnie
Berhane, Thomas  
Corpus, Sumaria  
Maple-Brown, Louise  
Abstract
Aboriginal people in remote Northern Territory communities experience the highest burden of type 2 diabetes (T2D) globally. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) improve cardiac and renal outcomes in selected populations. However, safety in this context is unknown. We investigated SGLT2i use and outcomes in remote Aboriginal people with T2D between 2012 and 2020.
Publication information
Intern Med J . 2025 Feb 24. doi: 10.1111/imj.16653. Online ahead of print.
File(s)
Loading...
Thumbnail Image
Name

Use of sodium–glucose cotransporter-2 inhibitors among.pdf

Description
Re-used under a Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/
Size

647.72 KB

Format

Adobe PDF

Checksum

(MD5):c75a2b7ac503dc7005dfd2d370a5cd6e

Date Issued
2025-02-24
Type
Journal Article
Subjects
general practice
indigenous health
pharmacoepidemiology
primary care
rural health service
type 2 diabetes
Journal Title
Internal medicine journal
Permanent link to this record
https://hdl.handle.net/10137/14159

NT Health Library Services acknowledges the Traditional Custodians of Country throughout the Northern Territory and recognises their continuing cultural and spiritual connections to the lands, waters, and communities. We pay our respects to elders past, present and emerging, and extend that respect to all Aboriginal and Torres Strait Islander people across the Northern Territory and beyond, many of whom are represented in our collections.

© 2025 Northern Territory Government of Australia